The appearance of TAOK activity at NFTs in AD and FTLD, and their phosphorylation of tau on multiple pathological sites, suggests that these proteins could offer novel and suitable alternative drug targets for the treatment of neurodegenerative disorders. The gene discussed is MAPT; the disease is Alzheimer disease.